Results 201 to 210 of about 94,535 (216)

Development of subtype-selective oestrogen receptor-based therapeutics

Nature Reviews Drug Discovery, 2011
Jan-Ake Gustafsson
exaly  

Obesity and adverse breast cancer risk and outcome: Mechanistic insights and strategies for intervention

Ca-A Cancer Journal for Clinicians, 2017
Cynthia Morata-Tarifa, Joyce M Slingerland   +1 more
exaly  

Targeting pathological B cell receptor signalling in lymphoid malignancies

Nature Reviews Drug Discovery, 2013
Ryan M Young, Louis M Staudt
exaly  

Fc receptor-targeted therapies for the treatment of inflammation, cancer and beyond

Nature Reviews Drug Discovery, 2012
P Mark Hogarth
exaly  

Transient receptor potential channels as therapeutic targets

Nature Reviews Drug Discovery, 2011
Magdalene M Moran, Arpad Szallasi
exaly  

[A new histaminergic receptor: H3-receptor].

Sheng li ke xue jin zhan [Progress in physiology], 1989
openaire   +1 more source

Physiological Roles of Histamine H3-Receptors

1989
J-M. ARRANG, M. GARBARG, J-C. LANCELOT, J-M. LECOMTE, H. POLLARD, M. ROBBA, W. SCHUNACK, J-C. SCHWARTZ   +7 more
openaire   +1 more source

Enabling the 'host jump': structural determinants of receptor-binding specificity in influenza A viruses

Nature Reviews Microbiology, 2014
Yi Shi, Jianxun Qi, George F Gao
exaly  

Histamine H3- Receptor Agonists and Antagonists

2008
Holger Stark, Walter Schunack
openaire   +1 more source

New Molecular Classifications of Breast Cancer

Ca-A Cancer Journal for Clinicians, 2009
exaly